Correction: AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies
Crossref DOI link: https://doi.org/10.1158/2159-8290.CD-19-0577
Published Online: 2019-07-01
Published Print: 2019-07-01
Update policy: https://doi.org/10.1158/crossmark_policy